iCAD announced the Board of Directors has approved the appointment of Eric Lonnqvist as Chief Financial Officer, CFO, effective immediately, as well as Vasu Avadhanula as Chief Product Officer, CPO, and Michelle Strong as Chief Operations Officer, COO, effective May 1. Eric Lonnqvist Appointed as Chief Financial Officer: Lonnqvist brings more than 15 years of finance and accounting experience in the medical device and technology industries. Vasu Avadhanula joins as Chief Product Officer: Avadhanula brings more than 25 years of product development, business analytics, and technology innovation experience in the healthcare and technology industries. Michelle Strong joins as Chief Operations Officer: Strong joins the Company with more than 25 years of experience in marketing and healthcare technology, most recently serving as VP of Marketing Strategy at Susan G. Komen.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ICAD:
- iCAD price target lowered to $4 from $7 at JMP Securities
- iCAD announces publication of clinical data for ProFound AI Risk
- ProFound AI Risk Outperforms Traditional, Widely-Accepted Breast Cancer Risk Models for Both Short-term and Long-term Risk Assessments
- iCAD price target lowered to $2.50 from $5 at Lake Street
- iCAD price target lowered to $3 from $4 at BTIG
